I
Inovio Pharmaceuticals, Inc. (INO)
NCM – Real vaqt narxi. Valyuta: USD
1.41
-0.02 (-1.40%)
Yopilishda: May 12, 2026, 4:00 PM EDT
1.45
+0.04 (2.58%)
Bozor oldidan: May 13, 2026, 4:10 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
1.41
-0.02 (-1.40%)
Yopilishda: May 12, 2026, 4:00 PM EDT
1.45
+0.04 (2.58%)
Bozor oldidan: May 13, 2026, 4:10 AM EDT
Inovio Pharmaceuticals, Inc., bir biotexnologiya kompaniyasi, inson papillomavirusi (HPV), saraton va yuqumli kasalliklar bilan bog'liq kasalliklarni davolash va himoya qilish uchun DNK dorilarini kashf qilish, ishlab chiqish va tijoratlashtirishga qaratilgan. Uning DNK dorilari platformasi SynCon texnologiyasidan foydalanadi, bu aniq ishlab chiqilgan plazmid DNK plazmidlarini muhandislik qilishga yordam beradi, shuningdek, DNK plazmidlarini etkazib berishni osonlashtiradigan CELLECTRA aqlli qurilmalar texnologiyasini o'z ichiga oladi. Kompaniyaning asosiy mahsulot nomzodi INO-3107 bo'lib, u HPV bilan bog'liq takroriy nafas olish papillomatozini davolash uchun mo'ljallangan va 1/2-faza sinovlarida. Uning quvur liniyasidagi mahsulotlari quyidagilarni o'z ichiga oladi: HPV bilan bog'liq bachadon bo'yni yuqori darajali skuamozi epiteliya lezyonlarini davolash uchun VGX-3100; HPV bilan bog'liq orofarengeal skuamozi hujayrali karsinomani davolash uchun INO-3112 va 2-faza sinovlarida; glioblastoma multiforme davolash uchun INO-5401 va 2-faza sinovlarida; Ebola Virus Kasalligi uchun INO-4201 va 1b-faza sinovlarida; COVID-19 uchun INO-4800 va 2/3-faza sinovlarida; va OIVni davolash uchun INO-6160 va 1-faza sinovlarida. Kompaniyaning sheriklari va hamkorlari ApolloBio Corporation, AstraZeneca, Coherus Biosciences, Defense Advanced Research Projects Agency, HIV Vaccines Trial Network, Kaneka Eurogentec, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter BioLogics, University of Pennsylvania va The Wistar Institute. Kompaniya 1983 yilda tashkil etilgan va shtab-kvartirasi Pensilvaniya shtatining Plymouth Meeting shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Jacqueline E. Shea Ph.D. | CEO, President & Director |
| Dr. Jeffrey Skolnik M.D. | Senior Vice President of Clinical Development |
| Dr. Laurent M. Humeau Ph.D. | Chief Scientific Officer & Chairman of the Scientific Advisory Board |
| Dr. Michael Sumner B.S., M.B.A., M.D. | Chief Medical Officer & Head of Development |
| Mr. E. J. Brandreth MBA | Senior Vice President of Quality Assurance |
| Mr. Peter D. Kies |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-07 | DEF 14A | ino-20260407.htm |
| 2026-04-06 | 8-K | d137120d8k.htm |
| 2026-04-02 | 8-K | d107839d8k.htm |
| 2026-03-12 | 8-K | ino-20260312.htm |
| 2025-12-29 | 8-K | d78035d8k.htm |
| 2025-11-10 | 8-K | ino-20251110.htm |
| 2025-11-10 | 10-Q | ino-20250930.htm |
| 2025-08-12 | 10-Q | ino-20250630.htm |
| 2025-07-07 | 8-K | d15686d8k.htm |
| 2025-05-22 | 8-K | ino-20250520.htm |
| Chief Financial Officer |
| Mr. Robert J. Juba Jr. | Senior Vice President of Biological Manufacturing & Clinical Supply Management |
| Mr. Robert L. Crotty J.D. | General Counsel, Corporate Secretary & Chief Compliance Officer |
| Mr. Shawn D. Bridy M.A., M.B.A. | Senior Vice President of Business Development |
| Ms. Jennie Willson | Director of Communications |